However, the crosstalk between MSCs and other cells in the tumour microenvironment cannot be ignored, such as immune cells and blood and lymphatic vessels. The interaction of cancer cells with stromal cells, immune cells or related cytokines promotes tumour growth and metastasis. 8 MSCs are multipotent cells with plastic ability, whose phenotype and immunomodulatory potential can be altered by the tumour microenvironment to promote tumour growth. Some results have shown that BM-MSCs can be transdifferentiated into GC-MSCs. 9 However, the exact mechanism is unclear, which may be related to immune cells. Some studies have indicated that macrophage-educated MSCs can promote inflammatory breast cancer. 10 Collaboration between cancerassociated fibroblasts and tumour-associated macrophages is essential for tumour progression, and the cells induce recruitment and activation of each other via cell-cell interaction. 11, 12 T cells are the dominant cell clusters in the tumour environment. MSCs, and inhibit T-cell proliferation via a contact-dependent mechanism. 17, 18 It has been shown previously that PD-1 is expressed in T cells as well as some types of human tumours. Melanoma cellintrinsic PD-1 can augment phosphorylated ribosomal protein S6
(p-S6) levels and enhance tumour growth in immunocompromised mice. 19 Here, we studied PD-L1 expression and its role in promoting GC growth of GC-MSCs primed by CD4 + T cells, and the mechanisms involved.
| MATERIALS AND METHODS

| Cell culture
The Ethical Committee of the Affiliated Hospital of Jiangsu University approved this study and all samples were obtained with informed consent. GC-MSCs were derived from human GC tissues, which were isolated and cultured as previously described. 20 
| Co-culture experiments
Gastric cancer mesenchymal stem cells were cultured for 24 hours in normal culture medium. The culture medium was collected as GC- Hoechst33342, and photographs were taken using a microscope (Olympus, Tokyo, Japan).
| Immunofluorescence
| RT-PCR
Total RNA was extracted from cells using Trizol reagent (Invitrogen).
The first-strand cDNA was synthesized from RNA using a reverse transcription kit (Vazyme, China). Quantitative RT-PCR (qRT-PCR)
for measurement of PD-L1 was performed using the Ultra SYBR Green PCR Kit (CWBIO, China) using CFX96 Touch Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). The primer sets are listed in Table 1 . PE-IgG and FITC-IgG were used as controls. 
| Flow cytometry
| Transwell migration assay
| Apoptosis assay
Apoptosis was evaluated using the FITC-Annexin V Apoptosis Detection Kit I (eBioscience). SGC-7901 cells were harvested at 48 hours after co-culture with control CM, GC-MSCs-CM and CD4 + T cell-primed GC-MSCs-CM. The fractions of viable, necrotic and apoptotic cells were detected and quantified by flow cytometry.
| Colony formation assay
SGC-7901 cells were seeded in six-well plates at 10 
| Western blotting
Cells or xenograft tumour tissues were lysed in RIPA buffer, and protein concentration was determined. A total of 100 μg protein was loaded and run on SDS gels, then transferred onto polyvinylidene difluoride mem- 
| Statistical analysis
Data were expressed as mean ± standard deviation (SD). Statistically significant differences were tested by t test or one-way analysis of variance.
For in vivo tumour growth experiment, the Kruskal-Wallis H test was used for statistical analysis. P < .05 was considered to be statistically significant. 
| RESULTS
| PD-L1 expression in GC-
| CD4 + T cells upregulated PD-L1 expression in
GC-MSCs by activating p-STAT3
We next examined which pathways were involved in PD-L1 expression in GC-MSCs. It is reported that many pathways tightly regulate PD-L1 expression. These data indicate that the p-STAT3 pathway plays an important role in CD4 + T-cell promotion of PD-L1 expression in GC-MSCs.
| Promotion of GC cell migration by CD4 + T cellprimed GC-MSCs
In the GC environment, tumour cells are affected by stromal cells and immune cells. We explored the role of GC-MSCs It has been reported that melanoma-expressed PD-L1 promotes tumour growth via combination with the melanoma PD-1 receptor and activation of downstream mTOR signalling. 19 We found that the PD-1 was expressed in many types of GC cell line ( Figure 5C ). Hence, we as- 
| DISCUSSION
Recent studies have reported that many kinds of tumour-associated
MSCs are involved in tumour progression. and STAT3 can bind to PD-L1 promoter, but STAT3 typically mediates PD-L1 transcription in cells. [37] [38] [39] We also found that p-STAT3 activation is related to PD-L1 expression, and the p-STAT3 pathway plays an important role in CD4 + T-cell promotion of PD-L1 expression in GC-MSCs.
In summary, our data suggested that CD4 + T cells upregulated PD-L1 expression in GC-MSCs via p-STAT3 signalling. CD4 + T cell-primed GC-MSCs promoted GC growth, via activating cancer cell-intrinsic PD-1/mTOR signalling. This reminds us that another PD-L1/PD-1 relevant regulatory approach may be present, which offers a novel underlying mechanism of GC progression.
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